(TLRY)’s latest quarterly results changed no broker’s disposition toward its stock but many analysts lowered their price targets for the Canadian cannabis firm’s shares, as Wall Street published research Wednesday morning. After Tilray (ticker: TLRY) reported on its September quarter Tuesday, Benchmark analyst Mike Hickey maintained his Buy rating for the stock. Among the analysts surveyed by FactSet, the average price target for Tilray is now $29. Read More...
(TLRY)’s latest quarterly results changed no broker’s disposition toward its stock but many analysts lowered their price targets for the Canadian cannabis firm’s shares, as Wall Street published research Wednesday morning. After Tilray (ticker: TLRY) reported on its September quarter Tuesday, Benchmark analyst Mike Hickey maintained his Buy rating for the stock. Among the analysts surveyed by FactSet, the average price target for Tilray is now $29.
Add Comment